Inhibition of peptic activity by carbenoxolone and glycyrrhetinic acid
Open Access
- 1 April 1970
- Vol. 11 (4) , 344-351
- https://doi.org/10.1136/gut.11.4.344
Abstract
Carbenoxolone (Biogastrone, Berk) has been shown to reduce the peptic activity and total acidity of gastric juice obtained from anaesthetized pylorus-ligated rats without affecting significantly the volume of gastric juice secreted or the K+ concentration. Glycyrrhetinic acid was less potent in reducing peptic activity and caused no reduction in total acidity. Antipeptic activity of carbenoxolone has also been demonstrated in vitro using the pepsin plate technique and the haemoglobin pepsin assay. It is suggested that these actions of carbenoxolone may contribute to the increased rate of healing of peptic ulcer in patients treated with the drug.Keywords
This publication has 23 references indexed in Scilit:
- A controlled trial of carbenoxolone sodium capsules in the treatment of duodenal ulcer.Gut, 1968
- Carrageenans and the proteolytic activity of human gastric secretionJournal of Pharmacy and Pharmacology, 1967
- Uncoupling of oxidative phosphorylation by glycyrrhetic acid, fusidic acid and some related triterpenoid acidsJournal of Pharmacy and Pharmacology, 1967
- Degraded and undegraded carrageenans and antipeptic activityJournal of Pharmacy and Pharmacology, 1967
- Assessment of possible glucocorticoid activity of carbenoxolone sodium.BMJ, 1967
- BIOGASTRONE IN INPATIENT TREATMENT OF GASTRIC ULCER: A Double-blind StudyThe Lancet, 1965
- Treatment of gastric ulcer with carbenoxolone sodium and oestrogensGut, 1965
- The Effect of a Sulphated Polysaccharide upon the Diffusion of Pepsin through MucinJournal of Pharmacy and Pharmacology, 1961
- The Antipeptic Activity of Sulphated PolysaccharidesJournal of Pharmacy and Pharmacology, 1961
- A COMPARATIVE IN VITRO EVALUATION OF A NEW BISMUTH SALT BISMUTH ALUMINATEJournal of Pharmacy and Pharmacology, 1958